Page last updated: 2024-08-23

daunorubicin and Viremia

daunorubicin has been researched along with Viremia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andreone, P; Bernardi, M; Calza, L; Chiodo, F; Giuliani, R; Manfredi, R; Tadolini, M; Trevisani, F; Verucchi, G; Zambruni, A1
Pozo, F; Rivero, A; Serrano, R; Tenorio, A; Torre-Cisneros, J; Vidal, E1

Trials

1 trial(s) available for daunorubicin and Viremia

ArticleYear
Patterns of lymphotropic herpesvirus viraemia in HIV-infected patients with Kaposi's sarcoma treated with highly active antiretroviral therapy and liposomal daunorubicin.
    AIDS (London, England), 2000, Sep-29, Volume: 14, Issue:14

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Daunorubicin; Didanosine; Drug Therapy, Combination; Herpesvirus 8, Human; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Sarcoma, Kaposi; Stavudine; Viremia

2000

Other Studies

1 other study(ies) available for daunorubicin and Viremia

ArticleYear
Human herpesvirus-8-related Kaposi's sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin.
    Transplant infectious disease : an official journal of the Transplantation Society, 2005, Volume: 7, Issue:1

    Topics: Antibiotics, Antineoplastic; Antiviral Agents; Cidofovir; Cytosine; Daunorubicin; Drug Therapy, Combination; Herpesvirus 8, Human; Humans; Immunocompromised Host; Liver Transplantation; Male; Middle Aged; Organophosphonates; Sarcoma, Kaposi; Viral Load; Viremia

2005